Stigma of Substance Use Disorder Varies by Condition, Provider
WEDNESDAY, July 30, 2025 -- Health care provider stigma toward substance use disorder (SUD) varies by condition and provider, according to a study published online July 23 in Addiction.
Carrigan L. Parish, Ph.D., from the Columbia Mailman School of Public Health in New York City, and colleagues quantified the prevalence and intensity of provider stigma toward patients with SUD by substance use type and compared with other conditions using a national probability sample survey, conducted from October 2020 to October 2022. Data were obtained from 1,240 randomly selected primary care physicians (PCPs) and emergency medicine physicians (EMPs) and dentists.
The researchers found the lowest stigma rating for diabetes and the highest for stimulant use disorders (mean, 23.2 and 36.3, respectively). Significantly higher stigma was seen toward opioid use disorder versus alcohol use disorder (effect size, 0.49), while stigma toward stimulant use disorders was significantly higher than toward opioid use disorder (effect size, 0.11). Significantly higher stigma scores were seen for EMPs than PCPs, while stigma scores were significantly higher for PCPs than dentists. There was an association for lower stigma scores with provision of SUD referrals (effect size, −0.37), providing medications (effect sizes, −0.44, −1.26, and −0.73 for alcohol, opioid, and stimulant use disorder, respectively), and having available SUD consultation (effect sizes, −0.48, −0.51, and −0.59 for alcohol, opioid, and stimulant use disorders, respectively).
"Our findings show that many providers still feel uncomfortable treating patients with substance use disorders and that hesitancy leads directly to missed opportunities for care," Parish said in a statement.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
One in 10 Undergoing Early Cancer Surgery Have New Persistent Opioid Use
MONDAY, Sept. 8, 2025 -- More than one in 10 veterans undergoing surgery for early-stage cancer develop new persistent opioid use, according to a study published online Sept. 8 in...
2000 to 2023 Saw Rise in Pediatric Exposure to Medications, Supplements
MONDAY, Sept. 8, 2025 -- From 2000 to 2023, the rate of exposure to medications, dietary supplements, and psychoactive substances increased among children aged 6 to 12 years...
Buprenorphine Available at 39.4 Percent of U.S. Pharmacies in 2023
WEDNESDAY, Sept. 3, 2025 -- From 2017 to 2023, there was an increase in buprenorphine availability overall, reaching 39.4 percent in 2023, according to a study published online...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.